BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. (BTAI) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 268 transactions totaling $75.3M, demonstrating a bearish sentiment with -$74.6M in net insider flow. The most recent transaction on Jan 9, 2026 involved a transaction of 17,000 shares valued at $0.
BTAI Insider Activity Summary
Who Is Buying BTAI Stock?
No significant insider buying has been recorded for BTAI in the recent period.
Who Is Selling BTAI Stock?
No significant insider selling has been recorded for BTAI in the recent period.
Is BioXcel Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BTAI is bearish with an Insider Alignment Score of 0/100 and a net flow of -$74.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
BTAI Frequently Asked Questions
Understanding BTAI Insider Activity
Insider trading at BioXcel Therapeutics, Inc. (BTAI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading BTAI stock, having executed 268 transactions in the past 90 days. The most active insider is Holdings, Inc. Bioxcel (Executive), who has made 9 transactions totaling $44.2M.
Related Tools
Track BioXcel Therapeutics, Inc. Insider Activity
Get notified when executives and directors at BTAI file new Form 4 transactions